Gustaf Brunius

483 total citations
23 papers, 321 citations indexed

About

Gustaf Brunius is a scholar working on Molecular Biology, Oncology and Pharmacy. According to data from OpenAlex, Gustaf Brunius has authored 23 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Pharmacy. Recurrent topics in Gustaf Brunius's work include Oral and gingival health research (6 papers), Peptidase Inhibition and Analysis (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Gustaf Brunius is often cited by papers focused on Oral and gingival health research (6 papers), Peptidase Inhibition and Analysis (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Gustaf Brunius collaborates with scholars based in Sweden, Japan and Germany. Gustaf Brunius's co-authors include Thomas Modéer, Tülay Yucel‐Lindberg, Ulf H. Lerner, Ingrid Bölin, Mitsuo Iinuma, Per‐Olof Berggren, Hans Erik Carlsson, Anders Thore, Thomas Olsson and Lisa Juntti‐Berggren and has published in prestigious journals such as Journal of Chromatography A, British Journal of Pharmacology and Applied Microbiology and Biotechnology.

In The Last Decade

Gustaf Brunius

22 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gustaf Brunius Sweden 13 111 109 44 43 39 23 321
Kazushi Kunimatsu Japan 11 91 0.8× 84 0.8× 9 0.2× 23 0.5× 15 0.4× 27 345
N Thyresson Sweden 16 119 1.1× 6 0.1× 8 0.2× 27 0.6× 9 0.2× 54 612
Enayat Attwa Egypt 11 99 0.9× 5 0.0× 13 0.3× 43 1.0× 6 0.2× 23 352
Yu‐Feng Huang Taiwan 9 85 0.8× 19 0.2× 10 0.2× 20 0.5× 3 0.1× 20 372
C. de la Torre Spain 10 175 1.6× 24 0.2× 12 0.3× 27 0.6× 13 0.3× 37 357
S Tomlin United Kingdom 8 85 0.8× 8 0.1× 11 0.3× 5 0.1× 7 0.2× 18 340
Katherine McD. Herrold United States 11 131 1.2× 8 0.1× 5 0.1× 55 1.3× 8 0.2× 13 405
Michel Pourtois Belgium 12 135 1.2× 10 0.1× 17 0.4× 1 0.0× 6 0.2× 33 337
K Seto Japan 9 81 0.7× 2 0.0× 10 0.2× 114 2.7× 32 0.8× 16 354
Hae‐Jin Hu South Korea 10 254 2.3× 5 0.0× 5 0.1× 16 0.4× 17 0.4× 24 438

Countries citing papers authored by Gustaf Brunius

Since Specialization
Citations

This map shows the geographic impact of Gustaf Brunius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gustaf Brunius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gustaf Brunius more than expected).

Fields of papers citing papers by Gustaf Brunius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gustaf Brunius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gustaf Brunius. The network helps show where Gustaf Brunius may publish in the future.

Co-authorship network of co-authors of Gustaf Brunius

This figure shows the co-authorship network connecting the top 25 collaborators of Gustaf Brunius. A scholar is included among the top collaborators of Gustaf Brunius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gustaf Brunius. Gustaf Brunius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yucel‐Lindberg, Tülay & Gustaf Brunius. (2006). Epidermal growth factor synergistically enhances interleukin-8 production in human gingival fibroblasts stimulated with interleukin-1β. Archives of Oral Biology. 51(10). 892–898. 18 indexed citations
2.
Brunius, Gustaf, et al.. (2004). Bradykinin upregulates IL-8 production in human gingival fibroblasts stimulated by interleukin-1β and tumor necrosis factor α. Regulatory Peptides. 126(3). 183–188. 16 indexed citations
3.
Yucel‐Lindberg, Tülay, et al.. (2001). Enhanced cyclooxygenase‐2 mRNA expression in human gingival fibroblasts induced by cell contact with human lymphocytes. European Journal Of Oral Sciences. 109(3). 187–192. 12 indexed citations
4.
Modéer, Thomas, et al.. (2000). Effect of phenytoin on the production of interleukin‐6 and interleukin‐8 in human gingival fibroblasts. Journal of Oral Pathology and Medicine. 29(10). 491–499. 35 indexed citations
5.
Brunius, Gustaf, Tülay Yucel‐Lindberg, Keiji Shinoda, & Thomas Modéer. (1996). Effect of phenytoin on interleukin‐1β production in human gingival fibroblasts challenged to tumor necrosis factor αin vitro. European Journal Of Oral Sciences. 104(1). 27–33. 20 indexed citations
6.
Brunius, Gustaf, et al.. (1993). The phenytoin metabolite p-HPPH upregulates prostaglandin biosynthesis in human gingival fibroblasts challenged to interleukin-1. Life Sciences. 53(6). 503–515. 5 indexed citations
7.
Brunius, Gustaf, et al.. (1992). Phenytoin potentiates interleukin‐1‐induced prostaglandin biosynthesis in human gingival fibroblasts. British Journal of Pharmacology. 106(3). 574–578. 24 indexed citations
8.
Lerner, Ulf H., et al.. (1992). Bradykinin induces a B2 receptor-mediated calcium signal linked to prostanoid formation in human gingival fibroblastsin vitro. Inflammation Research. 37(1-2). 44–52. 15 indexed citations
9.
Modéer, Thomas, Gustaf Brunius, Carlos F. Méndez, Lisa Juntti‐Berggren, & Per‐Olof Berggren. (1991). Influence of phenytoin on cytoplasmic free Ca2+ level in human gingival fibroblasts. European Journal Of Oral Sciences. 99(4). 310–315. 17 indexed citations
10.
Brunius, Gustaf, et al.. (1989). Effect of phenytoin on intracellular 45Ca2+ accumulation in gingival fibroblasts in vitro. Journal of Oral Pathology and Medicine. 18(8). 485–489. 23 indexed citations
11.
Frommer, Wolf B., Leigh Archer, Gustaf Brunius, et al.. (1989). Safe biotechnology. Applied Microbiology and Biotechnology. 30(6). 541–552. 17 indexed citations
12.
Rannug, Agneta, Mats J. Olsson, Leif Aringer, & Gustaf Brunius. (1988). An improved standardized procedure for urine mutagenicity testing.. PubMed. 396–400. 3 indexed citations
13.
Brunius, Gustaf, et al.. (1987). The effect of Ca2+ on the thermal stability of trypsin in phosphate-buffered saline solution used for harvesting of human embryonic lung fibroblast cultures. Journal of Biological Standardization. 15(3). 265–270. 5 indexed citations
14.
Brunius, Gustaf & Ingrid Bölin. (1983). Interaction between Yersinia pseudotuberculosis and the HeLa cell surface. Journal of Medical Microbiology. 16(3). 245–261. 17 indexed citations
15.
Brunius, Gustaf & Leif Holmquist. (1980). Desorption of neuraminidase activity fromα-N-acylneuraminic acid-sepharose carrying specifically bound influenza virus. FEMS Microbiology Letters. 9(1). 57–60. 1 indexed citations
16.
Brunius, Gustaf. (1980). PROLIFERATION OF Y. PSEUDOTUBERCULOSIS IN HeLa CELLS. FEMS Microbiology Letters. 7(1). 45–46. 4 indexed citations
17.
Brunius, Gustaf, et al.. (1980). Ingestion of Yersinia pseudotuberculosis into human fibroblasts in vitro.. PubMed. Suppl 24. 162–4. 1 indexed citations
18.
Brunius, Gustaf. (1980). Technical aspects of the use of 3′,6′-diacetyl fluorescein for vital fluorescent staining of bacteria. Current Microbiology. 4(6). 321–323. 41 indexed citations
19.
Olsson, Thomas, Gustaf Brunius, Hans Erik Carlsson, & Anders Thore. (1979). Luminescence immunoassay (LIA): A solid-phase immunoassay monitored by chemiluminescence. Journal of Immunological Methods. 25(2). 127–135. 23 indexed citations
20.
Brunius, Gustaf, Åke Bovallius, & Ingrid Bölin. (1978). Bactericidal effects of ampicillin and streptomycin on intracellular and extracellularYersinia pseudotuberculosis. Current Microbiology. 1(5). 297–299. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026